Custom Diagnostic & Research Antibody Services

Ulm Institute of Immunology, Germany

Dr. rer. nat. Rudolf Übelhart, Project Leader

“We collaborated on a project on generating a monoclonal antibody that recognizes a one-amino-acid mutation in a cancer-associated cell-surface protein. Although the project was technically challenging, we succeeded in generating a hybridoma clone that produced the desired antibody. In the course of the project, we found additional clones that recognized adjacent epitopes and Proteogenix put forth an effort to perform additional subclonings in order to ensure the delivery of clones that perfectly work. In summary, Proteogenix always strived to ensure maximal quality of the product and customer satisfaction, and the account Manager provided prompt and competent support at any time.”

Birmingham University, UK

Dr. Julie Rayes, Associate Professor

“I contacted ProteoGenix regarding the generation of monoclonal antibodies for the detection of a chemokine. ProteoGenix generated for us multiple monoclonal antibodies to detect the chemokine by ELISA, western blot and to test these antibodies in functional assays. They provided an excellent service, with regular updates, quick response to our queries and an excellent delivery of the product. I recommend their service for their efficacy and professionalism.”

Canopy Immuno-Therapeutics, Israel

Dr. Galit Denkberg, Vice-President Discovery

“We contacted ProteoGenix to develop repertoires of specific antibodies against three antigens sharing high homology. As determined by ELISA, ProteoGenix developed several specific antibodies that exhibited no cross-reactivity with the other antigens. We appreciated their proactive approach to increase our chances of success (e.g., performing fusions at their own risks). We are satisfied with the services of the company.”

Telum Therapeutics, Spain

Verónica Alcolea, Development Manager,

“We are thrilled with the success we’ve achieved through our collaboration with ProteoGenix in developing monoclonal antibodies targeting our protein. The antibodies they produced were not only highly selective but also demonstrated exceptional affinity for our target, significantly advancing our research.
ProteoGenix impressed us with their efficiency and speed throughout the process. Their commitment to providing excellent customer service made our experience even better, as they were always available to address our questions and concerns.
We highly recommend ProteoGenix to anyone in need of high-quality antibody development.”

Institut Jacques Monod, Paris

Dr. Valérie Doye, Group Leader

“We requested ProteoGenix’s services for the generation of anti-protein monoclonal antibodies to be used in our research. One antibody turned out to be an extremely good reagent, which received strong interest from Merck-Millipore and was eventually sold as part of a CNRS licence agreement in order to be added to Merck-Millipore’s products catalog. I’m definitely satisfied with ProteoGenix’s services!”